Cancer Clinical Trials

Clinical trials are research studies in which people help doctors find ways to improve health and cancer care. Each study tries to answer scientific questions and to find better ways to prevent, diagnose or treat cancer. Learn more about the different types and phases of clinical trials.

Why should I participate in a clinical trial?

Today it is possible to enroll in a clinical trial as the first step in your treatment after a cancer diagnosis. There are literally hundreds of trials available across the country. In fact, many of our most effective treatments used today for breast, colon, rectal and childhood cancers are the result of recent successes in clinical trials. As a participant a patient has the opportunity to help further the cause for other cancer patients, and possibly be helped by the treatments they receive. Participation in a clinical trial is voluntary. 

Below is a listing current treatment clinical trials for cancer offered through the Genesis Cancer Care Institute and Iowa Cancer Specialists. See clinical trials offered by Hematology-Oncology Associates of the Quad-Cities, PC

Each trial below is linked to a complete description provided by the National Cancer Institute. If you need assistance with this process, contact us

You may search for other clinical trials through the following links: National Cancer Institute Clinical Trial Search; Emerging Med; Trial Check; or Center Watch.

Showing 1-10 of 40

Sorted By:

  • Breast Cancer: A21102 (Hematology Oncology Associates)

    The purpose of this study is to compare the effects, good and/or bad, of testosterone, with a placebo (an inactive agent) on joint pain caused by taking aromatase inhibitors.

  • Breast Cancer: E2112 (Hematology Oncology Associates)

    The purpose of this study is find out what effects, both good and bad, an experimental drug called entinostat has on patients with breast cancer that is not able to be removed by surgery or has spread to another part of the body, when given together with the standard hormonal drug treatment, exemestane.

  • Breast Cancer: E2112 (Iowa Cancer Specialists)

    The purpose of this study is find out what effects, both good and bad, an experimental drug called entinostat has on patients with breast cancer that is not able to be removed by surgery or has spread to another part of the body, when given together with the standard hormonal drug treatment, exemestane.

  • Breast Cancer: NRG-BR003 (Hematology Oncology Associates)

    The purpose of this study is to compare the good and bad effects of the chemotherapy drug, carboplatin, given with the usual chemotherapy drugs after surgery, compared to the usual chemotherapy drugs given without carboplatin.

  • Breast Cancer: NRG-BR003 (Iowa Cancer Specialists)

    The purpose of this study is to compare the good and bad effects of the chemotherapy drug, carboplatin, given with the usual chemotherapy drugs after surgery, compared to the usual chemotherapy drugs given without carboplatin.

  • Breast Cancer: NSABP B-47 (Iowa Cancer Specialists)

    The main purpose of this study is to learn if adding a targeted therapy, trastuzumab (Herceptin®), to standard treatment with chemotherapy for early stage, HER2-low breast cancer, will prevent breast cancer from returning.

  • Breast Cancer: S1007 (Iowa Cancer Specialists)

    The purpose of this study is to determine the effect of chemotherapy in patients with node positive breast cancer who do not have high Recurrence Scores (RS) by Oncotype DX.

  • Breast Cancer: S1207 (Hematology Oncology Associates)

    The purpose of this study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without cancer returning for patients with hormone responsive breast cancer that have had their cancer removed by surgery and have completed required chemotherapy or radiation.

  • Breast Cancer: S1207 (Iowa Cancer Specialists)

    The purpose of this study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without cancer returning for patients with hormone responsive breast cancer that have had their cancer removed by surgery and have completed required chemotherapy or radiation.

  • Colon Cancer: CTSU 80702 (Hematology Oncology Associates)

    This randomized phase III trial is studying giving patients oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) together to compare how well they work when given together with or without celecoxib in treating patients with stage III colon cancer previously treated with surgery.

Page of 4, showing trials 1-10 of 40
Cancer Treatment and You

Cancer Treatment and You

Genesis Cancer Care Institute now has an online class providing general information about treatments and support services for cancer patients and families.

Start the class today!

Contact Us

For more information about our cancer services, please contact:

563-421-1909
800-446-6088
Email

Related Locations

Cancer Nurse Navigators

Do you or a loved one have cancer? Let our Cancer Nurse Navigators guide the way. Call us today.

563-421-1029
563-421-1030

Learn More

Related Classes/Events